Epidemiology of Coronavirus Disease 2019 at a County Jail-Alameda County, California, March 2020-March 2021
- PMID: 34797241
- DOI: 10.1097/PHH.0000000000001453
Epidemiology of Coronavirus Disease 2019 at a County Jail-Alameda County, California, March 2020-March 2021
Abstract
Context: Coronavirus disease 2019 (COVID-19) incidence rates are 2- to 5-fold higher among persons incarcerated in the United States than in the general population.
Program or policy: We describe an outbreak investigation of COVID-19 at a jail (jail A) in Alameda County during March 2020-March 2021.
Implementation: To prevent COVID-19 cases among incarcerated persons and employees, staff at jail A and the county public health department worked to develop and recommend infection control measures implemented by jail A including, but not limited to, face covering use among incarcerated persons and staff; cohorting incarcerated persons at a higher risk of severe COVID-19 in dedicated housing units; quarantining all newly detained individuals for 14 days; and offering testing for all symptomatic incarcerated persons, newly incarcerated persons at day 2 and day 10, and all persons who resided in a housing unit where a COVID-19 case was detected.
Evaluation: A total of 571 COVID-19 cases were detected among incarcerated persons at jail A during March 2020-March 2021, which represented a total incidence of 280 per 1000 population, 5 times higher than the rate in Alameda County. Of the 571 cases among incarcerated persons, 557 (98%) were male; 415 (73%) were aged 18 to 40 years; 249 (44%) were Latino; and 180 (32%) were African American; 354 (62%) were not symptomatic; and 220 (39%) had no comorbidities. Less than 2% of infected incarcerated persons were hospitalized, and no deaths were reported.
Discussion: COVID-19 disproportionately impacted persons incarcerated at jail A, with higher numbers among Latinos and African Americans. Implementation of COVID-19 infection control and testing measures, and collaboration between public health, law enforcement, and health care providers may have, in part, led to reductions in morbidity and mortality associated with COVID-19 at jail A.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare they have no conflicts of interest.
References
-
- Jiménez MC, Cowger TL, Simon LE, Behn M, Cassarino N, Bassett MT. Epidemiology of COVID-19 among incarcerated individuals and staff in Massachusetts jails and prisons. JAMA Netw Open. 2020;3(8):e2018851.
-
- Saloner B, Parish K, Ward JA, DiLaura G, Dolovich S. COVID-19 cases and deaths in federal and state prisons. JAMA. 2020;324(6):602–603.
-
- Kırbıyık U, Binder AM, Ghinai I, et al. Network characteristics and visualization of COVID-19 outbreak in a large detention facility in the United States—Cook County, Illinois, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1625–1630.
-
- Hagan LM, Williams SP, Spaulding AC, et al. Mass testing for SARS-CoV-2 in 16 prisons and jails—six jurisdictions, United States, April-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(33):1139–1143.
-
- Wallace M, Marlow M, Simonson S, et al. Public health response to COVID-19 cases in correctional and detention facilities—Louisiana, March-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):594–598.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical